12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok

Referencer:
Evens AM, Gartenhaus RB: Treatment of T-cell Non-Hodgkin’s lymphomas. Curr Treat Options Oncol. 2004
Aug;5 (4): 289-303
Deconinck E, Lamy T et al: Autologous stem cell transplantation for anaplastic large-cell lymphomas. Results of
a prospective trial. Br. J. of Haematol. (2000), 109, pp 736-742.
Weidmann E, Gramatzki M, Wilhelm M, Mitrou P S: Diagnosis and actual therapy strategies in peripheral T-cell
lymphomas: summary of an international meeting. Ann of Onc (2004) 15 pp 369-374
Jantunen E, D’Amore F: Stem cell transplantation for peripheral T-cell lymphomas. Leukemia and Lymphoma;
March2004 vol. 45, pp 441-446
Kahl C, Leihäuser M et al: Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and
autologous or allogeneic hematopoietic transplantation. Ann Hematol. (2002) 81: pp 646-650
Corradini P, Dodero A et al: Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin’s
lymphomas after reduced intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J.
Clin. Oncol. (2004) vol. 22 pp. 2172-2176
Zamkoff KW, Matulis MD et al: High-dose therapy and autologous stem cell transplant does not result in longterm
disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell
lymphoma. Bone Marrow Transplant.2004 Mar;33 (6):pp 635-638
Falini B, Pileri S et al: ALK+Lymphoma: Clinico-Pathological Findings and Outcome. Blood (April 15) 1999: pp
2697-2706
Gascoyne RD, aoun P et al: Prognostic significance of anaplastic lymphoma Kinase (ALK) Protein Expression in
Adults with Anaplastic Large Cell Lymphoma. Blood (June1) 1999: pp 3913-3921
Skinnider BF, Connors JM et al: Anaplastic Large Cell Lymphoma: A Clinocopathologic Analysis. Hematol.
Oncol. 1999;17. pp 137-148
Gallamini,A., Stelitano,C., Calvi,R., Bellei,M., Mattei,D., Vitolo,U., Morabito,F., Martelli,M., Brusamolino,E.,
Iannitto,E., Zaja,F., Cortelazzo,S., Rigacci,L., Devizzi,L., Todeschini,G., Santini,G., Brugiatelli,M., & Federico,M.
(2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective
multicentric clinical study. Blood, 103, 2474-2479.
Sonnen R, Schmidt W-P, Muller-Hermelink HK, Schmitz N (2005): The international prognostic index determines
the outcome of patients with nodal mature T-cell lymphomas Br. J. Haematol. 129: 366-372
Reimer P, Scherlin T, Rudiger T, Geissinger E, Roth S, Kunzmann V, Weissinger F, Nerl C, Schmitz N, Muller-
Hermelink HK, Wilhelm M (2004): Myeloablative radiochemotherapy followed by autologous peripheral blood
stem cell transplantation as first line therapy in peripheral T-cell lymphomas: first results of a prospective
multicenter study. Hematol J. 5 (4): 304-311
Herbert,K.E., Spencer,A., Grigg,A., Ryan,G., McCormack,C., & Prince,H.M. (2004) Graft-versus-lymphoma
effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell
transplantation. Bone Marrow Transplant., 34, 521-525.
87